Our biosimilars expert, Anna Rose Welch, talks about a new peer-reviewed paper that strongly suggests we “re-think biosimilar development following today’s regulatory science.” Check out her article “Show Me The Data: New Publication Moves Long-Held Regulatory Debate Forward” on BiosimilarDevelopment.com for more info on this topic.